Anti-Idiotype Monoclonal Antibody Carrying the Internal Image of Ganglioside GM3
- 21 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 82 (22) , 1757-1760
- https://doi.org/10.1093/jnci/82.22.1757
Abstract
Murine anti-idiotype monoclonal antibodies were generated against a human IgM monoclonal antibody (L612) that recognizes ganglioside GM3 on human melanoma. Hybridomas secreting antibodies that bound specifically to L612 were selected by enzyme-linked immu-nosorbent assay using L612 and three negative control human IgMs, including monoclonal anti-GM2 and anti–GD2 antibodies, as well as purifited serum IgM, as antigen sources. GM3–binding inhibition and cell–binding inhibition assays were used to identify seven antiidiotype monoclonal antibodies that recognized determinants located within the antigen-combining sites of L612. To determine whether these anti-idiotype monoclonal antibodies possessed the internal image of the original antigen, we immunized syngeneic BALB/c mice with one of the anti-idiotype monoclonal antibodies, 4C10, coupled with keyhole limpet hemocyanin. Sera from the immunized mice reacted strongly with an antigen-positive M12 melanoma cell line and with purified GM3. Because L612 detects and kills melanoma tumor cells in vitro and in vivo in the presence of complement without affecting normal tissues, anti-idiotype monoclonal antibodies carrying the internal image of GM3 may be an effective tool for active specific immunotherapy in patients with melanoma. [J Natl Cancer Inst 82: 1757–1760,1990]This publication has 15 references indexed in Scilit:
- Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.Proceedings of the National Academy of Sciences, 1987
- Gangliosides of Human Melanoma2JNCI Journal of the National Cancer Institute, 1987
- Syngeneic monoclonal internal image anti-idiotopes as prophylactic vaccines.The Journal of Immunology, 1986
- Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.Proceedings of the National Academy of Sciences, 1986
- Anti-Idiotypic Antibodies Bear the Internal Image of a Human Tumor AntigenScience, 1986
- Immunogenicity of melanoma‐associated gangliosides in cancer patientsInternational Journal of Cancer, 1985
- Ganglioside GM2 as a human tumor antigen (OFA-I-1).Proceedings of the National Academy of Sciences, 1983
- Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.Proceedings of the National Academy of Sciences, 1982
- Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.Proceedings of the National Academy of Sciences, 1982
- GANGLIOSIDES1964